TGF-β/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis
Open accessAbstract
The mechanisms by which TGF-β promotes lung adenocarcinoma (ADC) metastasis are largely unknown. Here, we report that in lung ADC cells, TGF-β potently induces expression of DOCK4, but not other DOCK family members, via the Smad pathway and that DOCK4 induction mediates TGF-β’s prometastatic effects by enhancing tumor cell extravasation. TGF-β-induced DOCK4 stimulates lung ADC cell protrusion, motility, and invasion without affecting epithelial-to-mesenchymal transition. These processes, which are fundamental to tumor cell extravasation, are driven by DOCK4-mediated Rac1 activation, unveiling a novel link between TGF-β and Rac1. Thus, our findings uncover the atypical Rac1 activator DOCK4 as a key component of the TGF-β/Smad pathway that promotes lung ADC cell extravasation and metastasis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Upregulation of DOCK4 was found associated with metastases of breast and lung cancer.
“Upregulation of DOCK4 was found associated with metastases of breast and lung cancer (39, 40).”
From miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer (2021) · cites this paper as [39]
The Results and Discussion support the lung-cancer portion: DOCK4 is upregulated by TGF-β in lung adenocarcinoma cells, and the paper reports a role for DOCK4 in lung adenocarcinoma metastasis. They do not support the breast-cancer portion; the paper reports no TGF-β-induced DOCK4 expression in breast cancer cells and no correlation between DOCK4 expression and breast-cancer relapse. No page numbers are available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922 · see citing works
Flagged first, then by citations
Research works printed but not linked: 53
- Akunuru S, Palumbo J, Zhai QJ, Zheng Y 2011 Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity. PLoS ONE 6: e16951. 21347385 PMC3036726
- Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Cespedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, 2012 Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22: 571– 584. 23153532 PMC3512565
- Cote JF, Vuori K 2002 Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J Cell Sci 115: 4901– 4913. 12432077
- Derynck R, Akhurst RJ, Balmain A 2001 TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29: 117– 129. 11586292
- Elliott RL, Blobe GC 2005 Role of transforming growth factor β in human cancer. J Clin Oncol 23: 2078– 2093. 15774796
- Feng H, Hu B, Jarzynka MJ, Li Y, Keezer S, Johns TG, Tang CK, Hamilton RL, Vuori K, Nishikawa R, 2012 Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis. Proc Natl Acad Sci 109: 3018– 3023. 22323579 PMC3286964
- Gadea G, Sanz-Moreno V, Self A, Godi A, Marshall CJ 2008 DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells. Curr Biol 18: 1456– 1465. 18835169
- Gaunt SJ, George M, Paul YL 2013 Direct activation of a mouse Hoxd11 axial expression enhancer by Gdf11/Smad signalling. Dev Biol 383: 52– 60. 24016758
- Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E 2009 Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11: 1287– 1296. 19838175 PMC2773241
- Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, 2009 Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 23: 2140– 2151. 19759262 PMC2751985
- Grant CE, Bailey TL, Noble WS 2011 FIMO: scanning for occurrences of a given motif. Bioinformatics 27: 1017– 1018. 21330290 PMC3065696
- Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim YY, 2011 An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial–mesenchymal transition. Mol Biol Cell 22: 1686– 1698. 21411626 PMC3093321
- Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K 2001 Transforming growth factor-β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91: 964– 971. 11251948
- Hiramoto K, Negishi M, Katoh H 2006 Dock4 is regulated by RhoG and promotes Rac-dependent cell migration. Exp Cell Res 312: 4205– 4216. 17027967
- Hoffman PC, Mauer AM, Vokes EE 2000 Lung cancer. Lancet 355: 479– 485. 10841143
- Isogaya K, Koinuma D, Tsutsumi S, Saito RA, Miyazawa K, Aburatani H, Miyazono K 2014 A Smad3 and TTF-1/NKX2-1 complex regulates Smad4-independent gene expression. Cell Res 24: 994– 1008. 25060702 PMC4123303
- Jakowlew SB 2010 Transforming growth factor-β in lung cancer, carcinogenesis, and metastasis. In The tumor microenvironment (ed. Bagley RG), pp. 633–671. Springer, New York.
- Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massague J 2003 A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537– 549. 12842083
- Kawada K, Upadhyay G, Ferandon S, Janarthanan S, Hall M, Vilardaga JP, Yajnik V 2009 Cell migration is regulated by platelet-derived growth factor receptor endocytosis. Mol Cell Biol 29: 4508– 4518. 19528233 PMC2725732
- Kennedy BA, Deatherage DE, Gu F, Tang B, Chan MW, Nephew KP, Huang TH, Jin VX 2011 ChIP-seq defined genome-wide map of TGFβ/SMAD4 targets: implications with clinical outcome of ovarian cancer. PLoS ONE 6: e22606. 21799915 PMC3143154
- Kobayashi M, Harada K, Negishi M, Katoh H 2014 Dock4 forms a complex with SH3YL1 and regulates cancer cell migration. Cell Signal 26: 1082– 1088. 24508479
- Labelle M, Begum S, Hynes RO 2011 Direct signaling between platelets and cancer cells induces an epithelial–mesenchymal-like transition and promotes metastasis. Cancer Cell 20: 576– 590. 22094253 PMC3487108
- Laurin M, Cote JF 2014 Insights into the biological functions of Dock family guanine nucleotide exchange factors. Genes Dev 28: 533– 547. 24637113 PMC3967044
- Laurin M, Huber J, Pelletier A, Houalla T, Park M, Fukui Y, Haibe-Kains B, Muller WJ, Cote JF 2013 Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis. Proc Natl Acad Sci 110: 7434– 7439. 23592719 PMC3645577
- Lund LR, Romer J, Ronne E, Ellis V, Blasi F, Dano K 1991 Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor β 1 in human A549 lung carcinoma cells. EMBO J 10: 3399– 3407. 1655420 PMC453068
- Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, Cheng AW, Lin F, Jiang S, Yeatman TJ, 2008 Extracellular matrix protein βig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 22: 308– 321. 18245446 PMC2216691
- Massague J 2008 TGFβ in cancer. Cell 134: 215– 230. 18662538 PMC3512574
- Massague J 2012 TGFβ signalling in context. Nat Rev Mol Cell Biol 13: 616– 630. 22992590 PMC4027049
- Meller N, Merlot S, Guda C 2005 CZH proteins: a new family of Rho-GEFs. J Cell Sci 118: 4937– 4946. 16254241
- Michl P, Ramjaun AR, Pardo OE, Warne PH, Wagner M, Poulsom R, D’Arrigo C, Ryder K, Menke A, Gress T, 2005 CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7: 521– 532. 15950902
- Morikawa M, Koinuma D, Tsutsumi S, Vasilaki E, Kanki Y, Heldin CH, Aburatani H, Miyazono K 2011 ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res 39: 8712– 8727. 21764776 PMC3203580
- Mullen AC, Orlando DA, Newman JJ, Loven J, Kumar RM, Bilodeau S, Reddy J, Guenther MG, DeKoter RP, Young RA 2011 Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell 147: 565– 576. 22036565 PMC3212730
- Nemunaitis J, Nemunaitis M, Senzer N, Snitz P, Bedell C, Kumar P, Pappen B, Maples PB, Shawler D, Fakhrai H 2009 Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients. Cancer Gene Ther 16: 620– 624. 19287371
- Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massague J 2009 WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138: 51– 62. 19576624 PMC2742946
- Padua D, Massague J 2009 Roles of TGFβ in metastasis. Cell Res 19: 89– 102. 19050696
- Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massague J 2008 TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66– 77. 18394990 PMC2390892
- Provencio M, Isla D, Sanchez A, Cantos B 2011 Inoperable stage III non-small cell lung cancer: current treatment and role of vinorelbine. J Thorac Dis 3: 197– 204. 22263088 PMC3256525
- Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ 2008 Rac activation and inactivation control plasticity of tumor cell movement. Cell 135: 510– 523. 18984162
- Schlenner SM, Weigmann B, Ruan Q, Chen Y, von Boehmer H 2012 Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med 209: 1529– 1535. 22908322 PMC3428940
- Scott J, Kuhn P, Anderson AR 2012 Unifying metastasis—integrating intravasation, circulation and end-organ colonization. Nat Rev Cancer 12: 445– 446. 22912952 PMC4533867
- Sethi N, Dai X, Winter CG, Kang Y 2011 Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 19: 192– 205. 21295524 PMC3040415
- Shibue T, Brooks MW, Weinberg RA 2013 An integrin-linked machinery of cytoskeletal regulation that enables experimental tumor initiation and metastatic colonization. Cancer Cell 24: 481– 498. 24035453 PMC3864118
- Siebert N, Xu W, Grambow E, Zechner D, Vollmar B 2011 Erythropoietin improves skin wound healing and activates the TGF-β signaling pathway. Lab Invest 91: 1753– 1765. 21894148
- Stoletov K, Kato H, Zardouzian E, Kelber J, Yang J, Shattil S, Klemke R 2010 Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci 123: 2332– 2341. 20530574 PMC2886748
- Strell C, Entschladen F 2008 Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal 6: 10. 19055814 PMC2627905
- Toonkel RL, Borczuk AC, Powell CA 2010 Tgf-β signaling pathway in lung adenocarcinoma invasion. J Thorac Oncol 5: 153– 157. 20101143 PMC2992959
- Tsai JH, Yang J 2013 Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27: 2192– 2206. 24142872 PMC3814640
- Valastyan S, Weinberg RA 2011 Tumor metastasis: molecular insights and evolving paradigms. Cell 147: 275– 292. 22000009 PMC3261217
- Vazquez PF, Carlini MJ, Daroqui MC, Colombo L, Dalurzo ML, Smith DE, Grasselli J, Pallotta MG, Ehrlich M, Bal de Kier Joffe ED, 2013 TGF-β specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer. Clin Exp Metastasis 30: 993– 1007. 23832740
- Yajnik V, Paulding C, Sordella R, McClatchey AI, Saito M, Wahrer DC, Reynolds P, Bell DW, Lake R, van den Heuvel S, 2003 DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell 112: 673– 684. 12628187
- Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, 2013 Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339: 580– 584. 23372014 PMC3760262
- Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, Liu F, Pan W, Wang TT, Zhou CC, 2014 A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25: 666– 681. 24768205
- Zhang YE 2009 Non-Smad pathways in TGF-β signaling. Cell Res 19: 128– 139. 19114990 PMC2635127
Cited by
Sorted by citations
miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer
Mei, Y., Li, K., Zhang, Z., Li, M., Yang, H., Wang, H., Huang, X., Li, X., Shi, S., & Yang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.740452 · Cited by 10 · see citing works
“Upregulation of DOCK4 was found associated with metastases of breast and lung cancer (39, 40).”
Background
- Authors
- Yu, J.-R., Tai, Y., Jin, Y., Hammell, M. C., Wilkinson, J. E., Roe, J.-S., Vakoc, C. R., & Van Aelst, L.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- University of Michigan (US)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-02-01
- Volume
- 29
- Issue
- 3
- Pages
- 250-261
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC4318142
- OpenAlex
- W1967801503
- Cited by
- 66
- References
- 1
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 5 · 2017: 9 · 2016: 6 · 2015: 1
- Type
- posted content
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Genes & Development (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Academic Commons (Stony Brook University) (submittedVersion)
- Funders
- National Institutes of Health (CA135053)
- New York STARR Foundation (14-A415/STARR)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- TGF-β/Smad signaling, DOCK4, lung adenocarcinoma, metastasis, tumor cell extravasation, Rac1 activation, cell motility, cell invasion, cell protrusions, epithelial-mesenchymal transition
- MeSH terms
- Adenocarcinoma of Lung, Adenocarcinoma, Animals, Humans, Lung Neoplasms, Neoplasm Metastasis, Signal Transduction, Gene Expression Regulation, Neoplastic, Transforming Growth Factor beta, GTPase-Activating Proteins, Cell Line, Tumor, Mice, Smad Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review